Financhill
Sell
20

IVF Quote, Financials, Valuation and Earnings

Last price:
$0.90
Seasonality move :
2.94%
Day range:
$0.86 - $0.92
52-week range:
$0.86 - $299.52
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.02x
P/B ratio:
--
Volume:
52.6K
Avg. volume:
729.6K
1-year change:
-99.61%
Market cap:
$13.2M
Revenue:
$6.5M
EPS (TTM):
-$635.94

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
IVF
INVO Fertility, Inc.
$1.8M -- -8.8% -- --
NMTC
NeuroOne Medical Technologies Corp.
$2.5M -- -54.48% -57.14% $2.23
NTRB
Nutriband, Inc.
$675K -$0.17 4.52% -54.85% $15.00
NVNO
enVVeno Medical Corp.
-- -$0.28 -- -9.68% $12.50
SINT
SINTX Technologies, Inc.
$200K -$0.55 -44.65% -56.43% $12.25
XAIR
Beyond Air, Inc.
$2.5M -$0.26 243.81% -8.29% $10.33
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
IVF
INVO Fertility, Inc.
$0.87 -- $13.2M -- $0.00 0% 0.02x
NMTC
NeuroOne Medical Technologies Corp.
$0.77 $2.23 $38.6M -- $0.00 0% 2.54x
NTRB
Nutriband, Inc.
$4.74 $15.00 $57.6M -- $0.00 0% 23.65x
NVNO
enVVeno Medical Corp.
$0.35 $12.50 $7.2M -- $0.00 0% 473.07x
SINT
SINTX Technologies, Inc.
$3.54 $12.25 $13.6M -- $0.00 0% 6.00x
XAIR
Beyond Air, Inc.
$0.82 $10.33 $3.8M -- $0.00 0% 3.66x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
IVF
INVO Fertility, Inc.
41.99% -0.446 10.12% 0.07x
NMTC
NeuroOne Medical Technologies Corp.
3.64% 2.039 0.6% 3.40x
NTRB
Nutriband, Inc.
3.31% 2.796 0.32% 7.07x
NVNO
enVVeno Medical Corp.
2.62% 2.197 4.32% 12.90x
SINT
SINTX Technologies, Inc.
45.47% 1.079 22.94% 1.47x
XAIR
Beyond Air, Inc.
48.09% 1.510 106.48% 2.68x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
IVF
INVO Fertility, Inc.
$492.6K -$1.6M -188.23% -471.28% -93.08% -$1.8M
NMTC
NeuroOne Medical Technologies Corp.
$1.5M -$1.4M -83.42% -89.54% -50.02% -$1.5M
NTRB
Nutriband, Inc.
$63K -$3.9M -159.71% -164.64% -1121.15% -$1.8M
NVNO
enVVeno Medical Corp.
-$120K -$4.9M -56.26% -57.7% -- -$4.4M
SINT
SINTX Technologies, Inc.
-$66K -$3.4M -115.95% -208.36% -1612.98% -$2.6M
XAIR
Beyond Air, Inc.
-$298K -$7.7M -126.53% -220.61% -421.4% -$4.7M

INVO Fertility, Inc. vs. Competitors

  • Which has Higher Returns IVF or NMTC?

    NeuroOne Medical Technologies Corp. has a net margin of -150.51% compared to INVO Fertility, Inc.'s net margin of -59.08%. INVO Fertility, Inc.'s return on equity of -471.28% beat NeuroOne Medical Technologies Corp.'s return on equity of -89.54%.

    Company Gross Margin Earnings Per Share Invested Capital
    IVF
    INVO Fertility, Inc.
    28.04% -$6.14 $10.1M
    NMTC
    NeuroOne Medical Technologies Corp.
    55.77% -$0.03 $7.3M
  • What do Analysts Say About IVF or NMTC?

    INVO Fertility, Inc. has a consensus price target of --, signalling upside risk potential of 16375.97%. On the other hand NeuroOne Medical Technologies Corp. has an analysts' consensus of $2.23 which suggests that it could grow by 190.55%. Given that INVO Fertility, Inc. has higher upside potential than NeuroOne Medical Technologies Corp., analysts believe INVO Fertility, Inc. is more attractive than NeuroOne Medical Technologies Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    IVF
    INVO Fertility, Inc.
    0 0 0
    NMTC
    NeuroOne Medical Technologies Corp.
    1 0 0
  • Is IVF or NMTC More Risky?

    INVO Fertility, Inc. has a beta of 2.540, which suggesting that the stock is 153.97% more volatile than S&P 500. In comparison NeuroOne Medical Technologies Corp. has a beta of 0.703, suggesting its less volatile than the S&P 500 by 29.673%.

  • Which is a Better Dividend Stock IVF or NMTC?

    INVO Fertility, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NeuroOne Medical Technologies Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. INVO Fertility, Inc. pays -- of its earnings as a dividend. NeuroOne Medical Technologies Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios IVF or NMTC?

    INVO Fertility, Inc. quarterly revenues are $1.8M, which are smaller than NeuroOne Medical Technologies Corp. quarterly revenues of $2.7M. INVO Fertility, Inc.'s net income of -$2.6M is lower than NeuroOne Medical Technologies Corp.'s net income of -$1.6M. Notably, INVO Fertility, Inc.'s price-to-earnings ratio is -- while NeuroOne Medical Technologies Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for INVO Fertility, Inc. is 0.02x versus 2.54x for NeuroOne Medical Technologies Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IVF
    INVO Fertility, Inc.
    0.02x -- $1.8M -$2.6M
    NMTC
    NeuroOne Medical Technologies Corp.
    2.54x -- $2.7M -$1.6M
  • Which has Higher Returns IVF or NTRB?

    Nutriband, Inc. has a net margin of -150.51% compared to INVO Fertility, Inc.'s net margin of -1118.87%. INVO Fertility, Inc.'s return on equity of -471.28% beat Nutriband, Inc.'s return on equity of -164.64%.

    Company Gross Margin Earnings Per Share Invested Capital
    IVF
    INVO Fertility, Inc.
    28.04% -$6.14 $10.1M
    NTRB
    Nutriband, Inc.
    18.2% -$0.32 $7.8M
  • What do Analysts Say About IVF or NTRB?

    INVO Fertility, Inc. has a consensus price target of --, signalling upside risk potential of 16375.97%. On the other hand Nutriband, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 216.46%. Given that INVO Fertility, Inc. has higher upside potential than Nutriband, Inc., analysts believe INVO Fertility, Inc. is more attractive than Nutriband, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    IVF
    INVO Fertility, Inc.
    0 0 0
    NTRB
    Nutriband, Inc.
    1 0 0
  • Is IVF or NTRB More Risky?

    INVO Fertility, Inc. has a beta of 2.540, which suggesting that the stock is 153.97% more volatile than S&P 500. In comparison Nutriband, Inc. has a beta of 1.907, suggesting its more volatile than the S&P 500 by 90.735%.

  • Which is a Better Dividend Stock IVF or NTRB?

    INVO Fertility, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nutriband, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. INVO Fertility, Inc. pays -- of its earnings as a dividend. Nutriband, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios IVF or NTRB?

    INVO Fertility, Inc. quarterly revenues are $1.8M, which are larger than Nutriband, Inc. quarterly revenues of $346.1K. INVO Fertility, Inc.'s net income of -$2.6M is higher than Nutriband, Inc.'s net income of -$3.9M. Notably, INVO Fertility, Inc.'s price-to-earnings ratio is -- while Nutriband, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for INVO Fertility, Inc. is 0.02x versus 23.65x for Nutriband, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IVF
    INVO Fertility, Inc.
    0.02x -- $1.8M -$2.6M
    NTRB
    Nutriband, Inc.
    23.65x -- $346.1K -$3.9M
  • Which has Higher Returns IVF or NVNO?

    enVVeno Medical Corp. has a net margin of -150.51% compared to INVO Fertility, Inc.'s net margin of --. INVO Fertility, Inc.'s return on equity of -471.28% beat enVVeno Medical Corp.'s return on equity of -57.7%.

    Company Gross Margin Earnings Per Share Invested Capital
    IVF
    INVO Fertility, Inc.
    28.04% -$6.14 $10.1M
    NVNO
    enVVeno Medical Corp.
    -- -$0.23 $30.2M
  • What do Analysts Say About IVF or NVNO?

    INVO Fertility, Inc. has a consensus price target of --, signalling upside risk potential of 16375.97%. On the other hand enVVeno Medical Corp. has an analysts' consensus of $12.50 which suggests that it could grow by 3423.11%. Given that INVO Fertility, Inc. has higher upside potential than enVVeno Medical Corp., analysts believe INVO Fertility, Inc. is more attractive than enVVeno Medical Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    IVF
    INVO Fertility, Inc.
    0 0 0
    NVNO
    enVVeno Medical Corp.
    0 1 0
  • Is IVF or NVNO More Risky?

    INVO Fertility, Inc. has a beta of 2.540, which suggesting that the stock is 153.97% more volatile than S&P 500. In comparison enVVeno Medical Corp. has a beta of 1.063, suggesting its more volatile than the S&P 500 by 6.264%.

  • Which is a Better Dividend Stock IVF or NVNO?

    INVO Fertility, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. enVVeno Medical Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. INVO Fertility, Inc. pays -- of its earnings as a dividend. enVVeno Medical Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios IVF or NVNO?

    INVO Fertility, Inc. quarterly revenues are $1.8M, which are larger than enVVeno Medical Corp. quarterly revenues of --. INVO Fertility, Inc.'s net income of -$2.6M is higher than enVVeno Medical Corp.'s net income of -$4.5M. Notably, INVO Fertility, Inc.'s price-to-earnings ratio is -- while enVVeno Medical Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for INVO Fertility, Inc. is 0.02x versus 473.07x for enVVeno Medical Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IVF
    INVO Fertility, Inc.
    0.02x -- $1.8M -$2.6M
    NVNO
    enVVeno Medical Corp.
    473.07x -- -- -$4.5M
  • Which has Higher Returns IVF or SINT?

    SINTX Technologies, Inc. has a net margin of -150.51% compared to INVO Fertility, Inc.'s net margin of -1701.44%. INVO Fertility, Inc.'s return on equity of -471.28% beat SINTX Technologies, Inc.'s return on equity of -208.36%.

    Company Gross Margin Earnings Per Share Invested Capital
    IVF
    INVO Fertility, Inc.
    28.04% -$6.14 $10.1M
    SINT
    SINTX Technologies, Inc.
    -31.73% -$3.46 $7.5M
  • What do Analysts Say About IVF or SINT?

    INVO Fertility, Inc. has a consensus price target of --, signalling upside risk potential of 16375.97%. On the other hand SINTX Technologies, Inc. has an analysts' consensus of $12.25 which suggests that it could grow by 246.05%. Given that INVO Fertility, Inc. has higher upside potential than SINTX Technologies, Inc., analysts believe INVO Fertility, Inc. is more attractive than SINTX Technologies, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    IVF
    INVO Fertility, Inc.
    0 0 0
    SINT
    SINTX Technologies, Inc.
    2 0 0
  • Is IVF or SINT More Risky?

    INVO Fertility, Inc. has a beta of 2.540, which suggesting that the stock is 153.97% more volatile than S&P 500. In comparison SINTX Technologies, Inc. has a beta of 0.633, suggesting its less volatile than the S&P 500 by 36.717%.

  • Which is a Better Dividend Stock IVF or SINT?

    INVO Fertility, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SINTX Technologies, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. INVO Fertility, Inc. pays -- of its earnings as a dividend. SINTX Technologies, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios IVF or SINT?

    INVO Fertility, Inc. quarterly revenues are $1.8M, which are larger than SINTX Technologies, Inc. quarterly revenues of $208K. INVO Fertility, Inc.'s net income of -$2.6M is higher than SINTX Technologies, Inc.'s net income of -$3.5M. Notably, INVO Fertility, Inc.'s price-to-earnings ratio is -- while SINTX Technologies, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for INVO Fertility, Inc. is 0.02x versus 6.00x for SINTX Technologies, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IVF
    INVO Fertility, Inc.
    0.02x -- $1.8M -$2.6M
    SINT
    SINTX Technologies, Inc.
    6.00x -- $208K -$3.5M
  • Which has Higher Returns IVF or XAIR?

    Beyond Air, Inc. has a net margin of -150.51% compared to INVO Fertility, Inc.'s net margin of -454.24%. INVO Fertility, Inc.'s return on equity of -471.28% beat Beyond Air, Inc.'s return on equity of -220.61%.

    Company Gross Margin Earnings Per Share Invested Capital
    IVF
    INVO Fertility, Inc.
    28.04% -$6.14 $10.1M
    XAIR
    Beyond Air, Inc.
    -16.39% -$1.25 $24.9M
  • What do Analysts Say About IVF or XAIR?

    INVO Fertility, Inc. has a consensus price target of --, signalling upside risk potential of 16375.97%. On the other hand Beyond Air, Inc. has an analysts' consensus of $10.33 which suggests that it could grow by 1165.56%. Given that INVO Fertility, Inc. has higher upside potential than Beyond Air, Inc., analysts believe INVO Fertility, Inc. is more attractive than Beyond Air, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    IVF
    INVO Fertility, Inc.
    0 0 0
    XAIR
    Beyond Air, Inc.
    2 1 0
  • Is IVF or XAIR More Risky?

    INVO Fertility, Inc. has a beta of 2.540, which suggesting that the stock is 153.97% more volatile than S&P 500. In comparison Beyond Air, Inc. has a beta of 0.304, suggesting its less volatile than the S&P 500 by 69.581%.

  • Which is a Better Dividend Stock IVF or XAIR?

    INVO Fertility, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Beyond Air, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. INVO Fertility, Inc. pays -- of its earnings as a dividend. Beyond Air, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios IVF or XAIR?

    INVO Fertility, Inc. quarterly revenues are $1.8M, which are smaller than Beyond Air, Inc. quarterly revenues of $1.8M. INVO Fertility, Inc.'s net income of -$2.6M is higher than Beyond Air, Inc.'s net income of -$8.3M. Notably, INVO Fertility, Inc.'s price-to-earnings ratio is -- while Beyond Air, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for INVO Fertility, Inc. is 0.02x versus 3.66x for Beyond Air, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IVF
    INVO Fertility, Inc.
    0.02x -- $1.8M -$2.6M
    XAIR
    Beyond Air, Inc.
    3.66x -- $1.8M -$8.3M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock